AJP - Lung Email Content Delivery
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Lung Cell Mol Physiol 291: L297-L300, 2006. First published April 28, 2006; doi:10.1152/ajplung.00138.2006
1040-0605/06 $8.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
291/3/L297    most recent
00138.2006v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Prince, A. S.
Right arrow Articles by Bhattacharya, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Prince, A. S.
Right arrow Articles by Bhattacharya, J.

EB2006 SYMPOSIUM REPORT

Cell signaling underlying the pathophysiology of pneumonia

Alice S. Prince,1 Joseph P. Mizgerd,2 Jeanine Wiener-Kronish,3 and Jahar Bhattacharya4

1Department of Pediatrics and Pharmacology, Columbia University, New York, New York; 2Harvard School of Public Health, Boston, Massachusetts; 3Department of Anesthesia and Perioperative Care, University of California San Francisco, San Francisco, California; and 4Lung Biology Laboratory, Columbia University & St. Luke's-Roosevelt Hospital Center, New York, New York

ABSTRACT

The symposium addressed the burgeoning interest in fundamental mechanisms underlying the onset of pneumonia. Bacteria exploit the lung's innate immune mechanism, resulting in pathophysiological cell signaling. As a consequence inflammation develops, leading to pneumonia. New mechanisms have been identified by which bacteria or bacterial products in the airway induce cross-compartmental signaling that leads to inflammatory consequences. The speakers addressed activation of the transcription factor, NF-{kappa}B occurring as a consequence of bacterial interactions with specific receptors, such as the Toll-like receptors and the TNF receptor 1 (Prince), or as a consequence of cytokine induction (Mizgerd). Also considered were mechanisms of bacterial virulence in the clinical setting (Wiener-Kronish) and the role of alveolar-capillary signaling mechanisms in the initiation of lung inflammation.



Address for reprint requests and other correspondence: J. Bhattacharya, 432 W. 58th St., Rm. 509, New York, NY 10019 (e-mail: jb39{at}columbia.edu)




This article has been cited by other articles:


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
J. P. Mizgerd and S. J. Skerrett
Animal models of human pneumonia
Am J Physiol Lung Cell Mol Physiol, March 1, 2008; 294(3): L387 - L398.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online
Copyright © 2006 by the American Physiological Society.